
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Although lowering antiretroviral-related high blood-lipid levels can be achieved either by switching from protease inhibitor'based therapy to a nonnucleoside drug or by adding lipid-lowering statin drugs to the mix, a study by researchers in Italy says the statin drugs could be a better choice. Reporting in the July 1 edition of the journal AIDS, they say that after one year of treatment with statin medications, study subjects posted a 41% triglyceride decrease when taking Pravachol and 47% for those taking bezafibrate. By comparison, lipid levels fell only 25% after one year for HIV patients who switched from a protease inhibitor to Viramune and 9% for those switching to Sustiva. Cholesterol levels also had a significantly greater decrease among study subjects adding lipid-lowering drugs to their regimens.
From our Sponsors
Most Popular
Plus: Featured Video